Workflow
NovaBay Pharmaceuticals Issues a Reminder of Important Information Regarding the Pending Special Dividend and Upcoming 2025 Annual Meeting
NovaBayNovaBay(US:NBY) Globenewswire·2025-09-18 20:30

Core Points - NovaBay Pharmaceuticals, Inc. announced a one-time special cash dividend of $0.80 per share for its common stock, payable on September 29, 2025, to stockholders of record as of September 15, 2025 [1] - The special dividend represents more than 25% of the stock price, leading to trading with "due bills" from the record date through the payment date [2] - Stockholders selling during the Dividend Right Period will forfeit their right to the special dividend, with due bills obligating sellers to deliver the dividend to buyers [3] - The CEO assured stockholders that the dividend payout will not hinder the company's ability to pursue strategic transactions, with an annual meeting scheduled for October 16, 2025 [4] - A preliminary proxy statement was filed with the SEC on September 10, 2025, with plans for a definitive proxy statement to be filed by the end of September [6] Company Actions - The company intends to hold its 2025 Annual Meeting of Stockholders on October 16, 2025, for stockholders of record on September 22, 2025 [4] - Stockholders are encouraged to read the definitive proxy statement and other relevant documents once available, as they will contain important information regarding the Investment Transaction [6][7] - The company and certain directors may be deemed participants in the solicitation of proxies related to the Investment Transaction, with details available in the preliminary and definitive proxy statements [8]